Bio-Thera Solutions Ltd (688177) - Cash Flow Conversion Efficiency

Latest as of June 2023: -0.054x

Based on the latest financial reports, Bio-Thera Solutions Ltd (688177) has a cash flow conversion efficiency ratio of -0.054x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-72.53 Million ≈ $-10.61 Million USD) by net assets (CN¥1.35 Billion ≈ $198.09 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Bio-Thera Solutions Ltd to measure how much of total assets are equity-financed.

Bio-Thera Solutions Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Bio-Thera Solutions Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 688177 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Bio-Thera Solutions Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bio-Thera Solutions Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shenzhen JingQuanHua Electronics Co Ltd SHE:002885	0.013x
Total Gabon F:RZW	0.045x
Zug Estates Holding AG SW:ZUGN	0.021x
New Pacific Metals Corp TO:NUAG	-0.005x
Green Plains Renewable Energy Inc NASDAQ:GPRE	-0.050x
L&C Bio Co. Ltd KQ:290650	0.014x
Tekla Healthcare Investors NYSE:HQH	0.008x
Yixin Group Limited F:1YX	-0.057x

Annual Cash Flow Conversion Efficiency for Bio-Thera Solutions Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Bio-Thera Solutions Ltd from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Bio-Thera Solutions Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥376.03 Million ≈ $55.03 Million	CN¥-82.11 Million ≈ $-12.02 Million	-0.218x	-177.83%
2024-12-31	CN¥708.09 Million ≈ $103.62 Million	CN¥-55.65 Million ≈ $-8.14 Million	-0.079x	+79.32%
2023-12-31	CN¥1.21 Billion ≈ $177.46 Million	CN¥-460.87 Million ≈ $-67.44 Million	-0.380x	-47.96%
2022-12-31	CN¥1.61 Billion ≈ $235.19 Million	CN¥-412.82 Million ≈ $-60.41 Million	-0.257x	-326.93%
2021-12-31	CN¥2.09 Billion ≈ $305.47 Million	CN¥236.27 Million ≈ $34.57 Million	0.113x	+163.40%
2020-12-31	CN¥2.01 Billion ≈ $293.48 Million	CN¥-358.04 Million ≈ $-52.39 Million	-0.179x	+81.17%
2019-12-31	CN¥630.67 Million ≈ $92.29 Million	CN¥-597.98 Million ≈ $-87.50 Million	-0.948x	-43.83%
2018-12-31	CN¥801.32 Million ≈ $117.26 Million	CN¥-528.25 Million ≈ $-77.30 Million	-0.659x	+3.20%
2017-12-31	CN¥347.55 Million ≈ $50.86 Million	CN¥-236.68 Million ≈ $-34.63 Million	-0.681x	-213.27%
2016-12-31	CN¥534.43 Million ≈ $78.20 Million	CN¥-116.18 Million ≈ $-17.00 Million	-0.217x	--

About Bio-Thera Solutions Ltd

SHG:688177 China Biotechnology

Market Cap

$1.06 Billion

CN¥7.28 Billion CNY

Market Cap Rank

#8645 Global

#2066 in China

Share Price

CN¥17.57

Change (1 day)

-1.84%

52-Week Range

CN¥16.10 - CN¥34.72

All Time High

CN¥71.90